ALBT logo

Avalon GloboCare Corp. Stock Price

NasdaqCM:ALBT Community·US$2.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

ALBT Share Price Performance

US$0.34
-3.50 (-91.15%)
US$0.34
-3.50 (-91.15%)
Price US$0.34

ALBT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

6 Risks
0 Rewards

Avalon GloboCare Corp. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$19.6m

Other Expenses

-US$19.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-2.36
0%
0%
10.7%
View Full Analysis

About ALBT

Founded
2015
Employees
2
CEO
Meng Li
WebsiteView website
www.avalon-globocare.com

Avalon GloboCare Corp., together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. Avalon GloboCare Corp. was founded in 2015 and is headquartered in Freehold, New Jersey.

Recent ALBT News & Updates

Recent updates

No updates